Public–Private Funding Leverage Trudeau Institute's recent federal and state funding milestones, including a $4.2 million federal investment and a $2.5 million DASNY CREST grant, to position strategic collaborations around funded research initiatives and co-development opportunities with pharma and biotech partners.

Facility Expansion Capitalize on ongoing investments to modernize research facilities in Saranac Lake with the aim of offering enhanced contract research, shared-use instrumentation access, and joint grant-funded projects for industry partners seeking scalable translational science capabilities.

Translational Network Target partnerships within the Trudeau Research Network and affiliated institutions (e.g., Walter Reed, SUNY Upstate, Einstein, Texas Biomed) to propose multi-center studies, data-sharing agreements, and collaborative programs that accelerate infectious disease solutions and clinical translation.

Immunology Expertise Position Trudeau’s focus on immunology and infectious diseases (TB, SARS-CoV-2, Zika, influenza, Powassan) to attract funding partners and suppliers offering AI-driven data analytics, high-containment lab services, diagnostic assay development, and pathogen-focused therapeutics.

Education & Talent Engage industry buyers with Trudeau’s education programs (Clarkson Trudeau Scholars, SURP) as talent pipelines and potential training-for-hire offerings, while marketing sponsored internships and sponsored research to biotech firms seeking skilled early-career researchers.